Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Ash2-like pseudogene (ENSG00000251585) is a nonfunctional DNA sequence in the human genome, derived from a former protein-coding gene (presumably related to the ASH2 gene family). Pseudogenes result from gene duplication or retrotransposition events that introduce mutations or regulatory defects, rendering them incapable of producing functional proteins[2][1]. As a pseudogene, ENSG00000251585 does not exhibit biological activity, known molecular function, disease association, or drug interaction. The classification of this gene as a pseudogene indicates that it does not serve as a therapeutic target, receptor, enzyme, transporter, or transcription factor[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ash2-like pseudogene.